Tissue engineering of heart valves - Immunologic and inflammatory challenges of the allograft scaffold

Progress in Pediatric Cardiology

Volumn 21, Issue 2, 2006, Pages 161-165

  Simon, Paul ^a   Kasimir, Marie Theres ^a   Rieder, Erwin ^a   Weigel, Guenter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Decellularization; Heart valve; Tissue engineering

Indexed keywords

ANTIGENICITY; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART VALVE BIOPROSTHESIS; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNE RESPONSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; TISSUE ENGINEERING;

EID: 33645031481     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2005.11.004     Document Type: Article

References (52)

1. S.C. Cannegieter, F.R. Rosendaal, and E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
2. S.C. Cannegieter, F.R. Rosendaal, and A.R. Wintzen Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 1995 11 17
3. F.M. Lupinetti, J. Warner, T.K. Jones, and S.P. Herndon Comparison of human tissues and mechanical prostheses for aortic valve replacement in children Circulation 96 1997 321 325
4. J.I. Fann, D.C. Miller, and K.A. Moore Twenty-year clinical experience with porcine bioprosthesis Ann Thorac Surg 62 5 1996 1301 1311
5. W. Vongpatanasin, D. Hillis, and R.A. Lange Prosthetic heart valves N Engl J Med 335 6 1996 407 416
6. R.C. Robbins, F.O. Bowman Jr., and J.R. Malm Cardiac valve replacement in children: a twenty year series Ann Thorac Surg 45 1988 56 61
7. D.B. Williams, G.K. Danielson, and D.C. McGoon Porcine heterograft valve replacement in children J Thorac Cardiovasc 85 1982 446 450
8. L. Solymar, P.S. Rao, M.K. Mardini, M.E. Fawzy, and G. Guinn Prosthetic valves in children and adolescents Am Heart J 121 1991 557 568
9. M.W. Turrentine, M. Ruzmetov, P. Vijay, R.G. Bills, and J.W. Brown Biological versus mechanical aortic valve replacement in children Ann Thorac Surg 71 suppl 5 2001 S356 S360
10. W.R. Jamieson, L.J. Rosado, and A.I. Munro Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve degeneration) by age groups Ann Thorac Surg 46 2 1988 155 162
11. J.C. Chambers, J. Somerville, S. Stone, and D.N. Ross Pulmonary autograft procedure for aortic valve disease; long-term results of the pioneer series Circulation 96 1997 2206 2214
12. P. Simon, C. Aschauer, and R. Moidl Growth of the pulmonary autograft after the Ross operation in childhood Eur J Cardiothorac Surg 19 2001 118 121
13. R.J. Baskett, D.B. Ross, M.A. Nanton, and D.A. Murphy Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity? J Thorac Cardiovasc Surg 112 5 1996 1170 1178
14. J. Stark, C. Bull, M. Stajevic, M. Jothi, M. Elliott, and M. de Leval Fate of subpulmonary homograft conduits: determinants of late homograft failure J Thorac Cardiovasc Surg 115 3 1998 506 514
15. J.S. Tweddell, A.N. Pelech, and P.C. Frommelt Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease Circulation 102 19 Suppl 3 2000 III130 III135
16. S. Neuenschwandner, and S.P. Hoerstrup Heart valve Tissue Eng Transpl Immunol 12 3-4 2004 359 365
17. K. Schenke-Layland, F. Opitz, and M. Gross Complete dynamic repopulation of decellularized heart valves by application of defined physical signals - an in vitro study Cardiovasc Res 60 3 2003 497 509
18. S.P. Hoerstrup, G. Zund, and S. Cheng A new approach to completely autologous cardiovascular tissue in humans ASAIO J 48 3 2002 234 238
19. S. Jockenhoevel, G. Zund, and S.P. Hoerstrup Fibrin gel - advantages of a new scaffold in cardiovascular Tissue Eng Eur J Cardio-Thorac Surg 19 4 2001 424 430
20. M. Grabenwöger, J. Sider, and F. Fitzal Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material Ann Thorac Surg 62 1996 772 777
21. F.J. Schoen, and R.J. Levy Bioprosthetic heart valve failure: pathology and pathogenesis Cardiol Clin 2 4 1984 717 739
22. F.J. Schoen, and R.J. Levy Heart valve anti-mineralization Eur J Cardiothorac Surg 6 Suppl I 1992 S91 S94
23. M.F. O'Brien, S. Goldstein, S. Walsh, K.S. Black, R. Elkins, and D. Clarke The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation Semin Thorac Cardiovasc Surg 11 suppl 1 1999 194 200
24. S.L. Hilbert, R. Yanagida, and J. Souza Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep J Heart Valve Dis 13 2004 831 840
25. G. Steinhoff, U. Stock, and N. Karim Tissue Engineering of pulmonary heart valves on allogenic acellular matrix conduits Circulation 102 2000 SIII50 SIII55
26. M.T. Kasimir, E. Rieder, and G. Seebacher Comparison of different decellularization procedures of porcine heart valves Int J Artif Organs 26 5 2003 421 427
27. E. Rieder, M.T. Kasimir, and G. Silberhumer Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells J Thorac Cardiovasc Surg 172 2004 399 405
28. M.T. Kasimir, E. Rieder, G. Seebacher, E. Wolner, G. Weigel, and P. Simon Presence and elimination of the Xenoantigen Gal (α1,3)Gal in tissue engineered heart valves Tissue Eng 11 2005 1274 1279
29. M.S. Sandrin, and I.F. McKenzie Gal alpha(1,3)Gal, the major xenoantigen (s) recognised in pigs by human natural antibodies Immunol Rev 141 1994 169 190
30. J.L. Platt, R.J. Fischel, A.J. Matas, S.A. Reif, R.M. Bolman, and F.H. Bach Immunopathology of hyperacute xenograft rejection in a swine to primate model Transplantation 52 1991 214 220
31. K.R. Stone, A.W. Walgenbach, J.T. Abrams, J. Nelson, N. Gillett, and U. Galili Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection Transplantation 63 1997 640 645
32. K.Z. Konakci, B. Bohle, and R. Blumer Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery Eur J Clin Invest 35 1 2005 17 23
33. G. Murray Homologous aortic valve segment transplants for aortic and mitral insufficiency Angiology 7 1956 466 471
34. R.O. Heimbecker, H.E. Aldrige, and G. Lemire The durability and fate of aortic valve grafts. An experimental study with a long term follow-up of clinical patients J Cardiovasc Surg (Torino) 9 6 Nov-Dec 1968 511 517
35. A.G. Kerwin, S.C. Lenkei, and D.R. Wilson Aortic valve homograft in the treatment for aortic and mitral insufficiency N Engl J Med 266 1962 852 857
36. P. Hogan, L. Duplock, and M. Green Human aortic valve allografts elicit a donor-specific immune response J Thorac Cardiovasc Surg 112 5 1996 1260 1266
37. F.M. Hoekstra, M. Witvliet, and C.Y. Knoop Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies Ann Thorac Surg 66 6 1998 2022 2026
38. R.C. Elkins, M.M. Lane, S.B. Capps, C. McCue, and P.E. Dawson Humoral immune response to allograft valve tissue pretreated with an antigen reduction process Semin Thorac Cardiovasc Surg 13 4 Suppl 1 2001 82 86
39. F.D. da Costa, P.M. Dohmen, and D. Duarte Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation Eur J Cardiothorac Surg 27 4 2005 572 578
40. J.F. Bechtel, J. Gellissen, and A.W. Erasmi Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts Eur J Cardiothorac Surg 27 3 2005 410 415
41. R.C. Elkins, S. Goldstein, and C.W. Hewitt Recellularization of heart valve grafts by a process of adaptive remodeling Semin Thorac Cardiovasc Surg 13 4 Suppl 1 2001 87 92
42. P. Simon, M.T. Kasimir, and G. Seebacher Early failure of the tissue engineered porcine heart valve Synergraft™ in paediatric patients Eur J Cardio-Thorac Surg 23 2003 1002 1006
43. M.T. Kasimir, G. Weigel, and J. Sharma The decellularized porcine heart valve matrix in Tissue Eng: platelet adhesion and activation Thromb Haemost 94 2005 562 567
44. D.D. Wagner, and P. Burger Platelet in inflammation and thrombosis Arterioscler Thromb Vasc Biol 23 2003 2131 2137
45. M.B. Gorbet, and M.V. Sefton Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets J Biomed Mater Res A 67 3 2003 792 800
46. T.G. Diacovo, S.J. Roth, J.M. Buccola, D.F. Bainton, and T.A. Springer Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18 Blood 88 1 1996 146 157
47. M.H. Wilhelmi, P. Rebe, R. Leyh, M. Wilhelmi, A. Haverich, and H. Mertsching Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep Int J Artif Organs 26 5 2003 411 420
48. M.J. Caterina, and P.N. Devreotes Molecular insights into eukaryotic chemotaxis FASEB J 5 15 1991 3078 3085
49. E. Rieder, G. Seebacher, and M.T. Kasimir Tissue Engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells Circulation 111 2005 2792 2797
50. S.R. Coughlin Thrombin signalling and protease-activated receptors Nature 407 6801 2000 258 264
51. L. Osborn Leukocyte adhesion to endothelium in inflammation Cell 62 1990 3 6
52. A. Mantovani, F. Bussolino, and E. Dejana Cytokine regulation of endothelial cell function FASEB 6 1992 2591 2599